Mostrando 2 resultados de: 2
Filtros aplicados
Subtipo de publicación
Article(2)
Área temáticas
Enfermedades(1)
Ginecología, obstetricia, pediatría, geriatría(1)
Medicina forense; incidencia de enfermedades(1)
Año de Publicación
2022(2)
Origen
scopus(2)
Disparities in Dolutegravir Uptake Affecting Females of Reproductive Age With HIV in Low- and Middle-Income Countries After Initial Concerns About Teratogenicity An Observational Study
ArticleAbstract: Background: The transition to dolutegravir-containing antiretroviral therapy (ART) in low- and middlPalabras claves:Autores:Avihingsanon A., Azwa I., Bernard C., Bijker R., Brazier E., Bui H.V., Cahn P., Cardoso S.W., Castelnuovo B., Cesar C., Chaiwarith R., Chan Y.J., Chitalikar A., Choi J.Y., Chumla L., Cortés C.P., Dell'Isola E., Ditangco R., Do C.D., Edwards J.K., Ezhilarasi C., Fink V., Gaikwad S., Gani Y.M., Gatechompol S., Grinsztejn B., Han N., Humphrey J.M., Imran D., Jiamsakul A., Joshi K., Kamarulzaman A., Kambua P., Kantipong P., Ke E., Kelvin E.A., Khol V., Khuwuwan S., Kiertiburanakul S., Kim J.M., Ku W.W., Kumarasamy N., Kunzekwenyika C., Lam W., Law M.G., Lee L.S., Lee M.P., Li P.C.K., Lim P.L., Ly P.S., Maina M.W., Mationg M.L., Matthew L. Romo, Merati T.P., Musick B.S., Na S., Nash D., Ng O.T., Ngo A.V., Nguyen D.T., Nguyen D.T.H., Nguyen K.V., Nguyen L.T., Nishijima T., Nuket K., Oka S., Panczak R., Pasayan M.K., Patel R.C., Penner J., Perez H., Petersen B., Phadungphon C., Phanuphak P., Phuphuakrat A., Ponnampalavanar S., Praparattanapan J., Pujari S., Ross J.L., Rudi N.B., Rupasinghe D., Sanmeema N., Sirisanthana T., Sohn A.H., Sued O., Syed Omar S.F., Tanuma J., Valiente J., Widhani A., Wirawan D.N., Wong H.Y., Wools-Kaloustian K.K., Wu P.C., Wyka K., Yamamoto C., Yap J.K., Yuliana F., Yunihastuti E., Zhang F.J., Zhao H.X.Fuentes:scopusReal-world use and outcomes of dolutegravir-containing antiretroviral therapy in HIV and tuberculosis co-infection: a site survey and cohort study in sub-Saharan Africa
ArticleAbstract: Introduction: Dolutegravir is being scaled up globally as part of antiretroviral therapy (ART), butPalabras claves:antiretroviral agents, antitubercular agents, drug interactions, HIV integrase inhibitors, Observational Study, rifampinAutores:Brazier E., Chimbetete C., De Waal R., Diero L., Dzudie A., Ezechi O.C., Fenner L., Kunzekwenyika C., Lelo P., Mahambou-Nsondé D., Matthew L. Romo, Muhairwe J.A., Murenzi G., Muyindike W.R., Nash D., Rafael I., Sekaggya-Wiltshire C., Shah N.S., Tiendrebeogo T., Twizere C., Wools-Kaloustian K.K., Yotebieng M.Fuentes:scopus